EFC AND M2BIO SCIENCES ANNOUNCE PIONEERING PARTNERSHIP

October 5, 2022October 5, 2022

JOHANNESBURG, SOUTH AFRICA – EFC and M2Bio Sciences are proud to be announcing a major new partnership that will revolutionise sport science and athlete health, not only in South Africa but throughout the world! With EFC leading the way in medical precaution and care of contact sports athletes, world-leading bioceutical company M2Bio Sciences which is at the cutting-edge of cannabinoid and psilocybin research in the treatment of brain health amongst many other ailments, connected with EFC to collaborate in the field of neurotrauma.

In this groundbreaking agreement, M2Bio Sciences will integrate their research program with the brain health of EFC competitors, whilst presenting a health and wellness product range which is being developed with EFC Lightweight Contender, Rob Simbowe.

Furthermore, M2Bio Sciences will contribute to the doubling of investment in EFC athletes that will enhance athlete pay whilst ensuring the roster continues to benefit from the best medical support available.